PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer
Author
McCubrey, James A.
Subject
Date
2017-02-21
Citation:
APA:
McCubrey, James A.. (February 2017).
PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer.
,
(),
-
. Retrieved from
http://hdl.handle.net/10342/9643
MLA:
McCubrey, James A..
"PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer". .
. (),
February 2017.
June 29, 2024.
http://hdl.handle.net/10342/9643.
Chicago:
McCubrey, James A.,
"PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer," , no.
(February 2017),
http://hdl.handle.net/10342/9643 (accessed
June 29, 2024).
AMA:
McCubrey, James A..
PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer. .
February 2017;
():
.
http://hdl.handle.net/10342/9643. Accessed
June 29, 2024.
Collections